FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

REGISTER

now for free

An Hermans

Research Profile

Disorders

Chemicals & Drugs

Procedures

Physiology

Action Potentials

Anatomy

Occupations

Electrophysiology

Living Beings

Rabbits

Concepts & Ideas

Register to see full profile

Co-author Network

Register to see all co-authors

Publications

TOP 3
Hua Rong Lu; An Hermans; David Gallacher
Does terfenadine-induced ventricular tachycardia/fibrillation directly relate to its QT prolongation and Torsades de Pointes?
Robertson (Rob) Towart; Joannes T M Linders; An Hermans; Jutta Rohrbacher; Henk J van der Linde; Martine Ercken; Miroslav Cik; Peter Roevens; Ard Teisman; David Gallacher
Blockade of the I(Ks) potassium channel: an overlooked cardiovascular liability in drug safety screening?
Hua Rong Lu; Eddy Vlaminckx; Andre Van de Water; Jutta Rohrbacher; An Hermans; David Gallacher
In-vitro experimental models for the risk assessment of antibiotic-induced QT prolongation.

Register to see all publications

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Register to see more

Geonetwork of An Hermans (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Register to see more

All Publications

2012: Hua Rong Lu; An Hermans; David Gallacher
Does terfenadine-induced ventricular tachycardia/fibrillation directly relate to its QT prolongation and Torsades de Pointes?
British journal of pharmacology 2012;166(4):1490-502.
2009: Robertson (Rob) Towart; Joannes T M Linders; An Hermans; Jutta Rohrbacher; Henk J van der Linde; Martine Ercken; Miroslav Cik; Peter Roevens; Ard Teisman; David Gallacher
Blockade of the I(Ks) potassium channel: an overlooked cardiovascular liability in drug safety screening?
Journal of pharmacological and toxicological methods 2009;60(1):1-10.
2007: Hua Rong Lu; Eddy Vlaminckx; Andre Van de Water; Jutta Rohrbacher; An Hermans; David Gallacher
In-vitro experimental models for the risk assessment of antibiotic-induced QT prolongation.
European journal of pharmacology 2007;577(1-3):222-32.
2007: David Gallacher; Andre Van de Water; Henk van der Linde; An Hermans; Hua Rong Lu; Rob Towart; Paul G A Volders
In vivo mechanisms precipitating torsades de pointes in a canine model of drug-induced long-QT1 syndrome.
Cardiovascular research 2007;76(2):247-56.
2006: Hua Rong Lu; Eddy Vlaminckx; Andre Van de Water; Jutta Rohrbacher; An Hermans; David Gallacher
In-vitro experimental models for the risk assessment of antibiotic-induced QT prolongation.
European journal of pharmacology 2006;553(1-3):229-39.
2005: Adrienne E Dubin; Nadia Nasser; Jutta Rohrbacher; An Hermans; Roger Marrannes; Christopher Grantham; Koen Van Rossem; Miroslav Cik; Sandra R Chaplan; David Gallacher; Jia Xu; Antonio Guia; Nicholas G Byrne; Chris Mathes
Identifying modulators of hERG channel activity using the PatchXpress planar patch clamp.
Journal of biomolecular screening 2005;10(2):168-81.
2002: Fred De Clerck; Andre Van de Water; Jan D'Aubioul; Hua Rong Lu; Koen van Rossem; An Hermans; Karel Van Ammel
In vivo measurement of QT prolongation, dispersion and arrhythmogenesis: application to the preclinical cardiovascular safety pharmacology of a new chemical entity.
Fundamental & clinical pharmacology 2002;16(2):125-40.

Register to see more

Copyright © 2011 Elsevier Inc. All rights reserved.